IR@PKUHSC  > 北京大学基础医学院  > 免疫学系
学科主题基础医学
Identification of promiscuous HLA-DR-restricted CD4(+) T-cell epitopes on the cancer-testis antigen HCA587
Wen, Weigang1; Zhang, Lijie1; Peng, Jirun2; Chen, Juanjuan1; Hao, Jiaqing1; Li, Xiaofeng1; Qian, Xiaoping1; Zeng, Pumei1; Zhang, Yu1; Yin, Yanhui1
刊名CANCER SCIENCE
2011-08-01
DOI10.1111/j.1349-7006.2011.01986.x
102期:8页:1455-1461
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]HEPATOCELLULAR-CARCINOMA ; IMMUNE-RESPONSES ; DENDRITIC CELLS ; PEPTIDE EPITOPE ; HIGH-THROUGHPUT ; TUMOR-ANTIGENS ; IFN-GAMMA ; IN-VIVO ; MELANOMA ; ANTITUMOR
英文摘要

The cancer testis antigen HCA587 is an attractive candidate for T cell-based immunotherapy because it is overexpressed in a wide spectrum of malignant tumors but not normal tissues, except testis. Several CTL epitopes derived from HCA587 have been described. Our aim was to identify helper T lymphocyte epitopes of HCA587 for the optimization of T cell-based immunotherapies against HCA587-expressing tumors. Candidate helper T lymphocyte epitopes for HCA587 were predicted using the SYFPEITHI algorithm and were tested for their ability to induce helper T lymphocyte responses by in vitro peptide vaccination of CD4(+) T lymphocytes from healthy individuals and hepatocellular carcinoma patients. Four CD4(+) T-cell epitopes for HCA587 (p43-57, p145-159, p186-200 and p249-263) were identified. Among them, the p43-57 epitope was shown to be naturally processed and presented by HCA587-expressing tumor cells as well as autologous dendritic cells pulsed with whole-protein HCA587. Notably, this epitope behaved as a promiscuous T-cell epitope as it stimulated T cells in the context of more than one HLA class II allele. Thus, p43-57 is the first HCA587-derived major histocompatibility complex class II-restricted epitope to fulfil all prerequisites for use as a peptide vaccine in patients with HCA587-expressing tumors. (Cancer Sci 2011; 102: 1455-1461)

语种英语
WOS记录号WOS:000292863700004
项目编号2006AA02Z486 ; 7071006
资助机构National 863 High Technology Program of China ; Beijing Municipal Government Foundation for Natural Sciences
引用统计
被引频次:8[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
版本出版稿
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63502
专题北京大学基础医学院_免疫学系
北京大学基础医学院
作者单位1.Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100871, Peoples R China
2.Peking Univ, Peoples Hosp, Ctr Hepatobiliary Surg, Hlth Sci Ctr, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Wen, Weigang,Zhang, Lijie,Peng, Jirun,et al. Identification of promiscuous HLA-DR-restricted CD4(+) T-cell epitopes on the cancer-testis antigen HCA587[J]. CANCER SCIENCE,2011,102(8):1455-1461.
APA Wen, Weigang.,Zhang, Lijie.,Peng, Jirun.,Chen, Juanjuan.,Hao, Jiaqing.,...&Yin, Yanhui.(2011).Identification of promiscuous HLA-DR-restricted CD4(+) T-cell epitopes on the cancer-testis antigen HCA587.CANCER SCIENCE,102(8),1455-1461.
MLA Wen, Weigang,et al."Identification of promiscuous HLA-DR-restricted CD4(+) T-cell epitopes on the cancer-testis antigen HCA587".CANCER SCIENCE 102.8(2011):1455-1461.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Wen_et_al-2011-Cance(237KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wen, Weigang]的文章
[Zhang, Lijie]的文章
[Peng, Jirun]的文章
百度学术
百度学术中相似的文章
[Wen, Weigang]的文章
[Zhang, Lijie]的文章
[Peng, Jirun]的文章
必应学术
必应学术中相似的文章
[Wen, Weigang]的文章
[Zhang, Lijie]的文章
[Peng, Jirun]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Wen_et_al-2011-Cancer_Science.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。